Headshot of Robert Froemke.

Robert Froemke

Skirball Foundation Professor of Genetics
NYU Grossman School of Medicine

Robert Froemke is Skirball Foundation Professor of Genetics in the Neuroscience Institute and the otolaryngology and neuroscience departments at NYU Grossman School of Medicine. His lab studies neuromodulation, plasticity and behavior in rodents and humans. Froemke has a background in systems neuroscience, having performed Ph.D. work with Yang Dan at the University of California, Berkeley on spike-timing-dependent plasticity induced by natural spike trains in cortical networks. His postdoctoral research with Christoph Schreiner at the University of California, San Francisco focused on synaptic plasticity in vivo as related to auditory perception and behavior.

Froemke started his faculty position at NYU Grossman School of Medicine in 2010. He studies the synaptic mechanisms by which sounds acquire meaning, with a focus on oxytocin, maternal behavior and the use of neuroprosthetic devices, such as cochlear implants. For this work, he was awarded Sloan and Klingenstein Fellowships, and Pew and McKnight Scholarships. In 2021, Froemke was honored to receive a Landis Award for Outstanding Mentorship from the National Institute of Neurological Disorders and Stroke.

Explore more from The Transmitter

Research image of lesion network mapping.

‘Overdue’ debate unfurls over neuroimaging method

After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.

By Angie Voyles Askham
17 April 2026 | 8 min read
Research image of zebrafish brain activity.

Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish

Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.

By Charles Q. Choi
16 April 2026 | 4 min read
NINDS building.

What neuroscientists want from a new NINDS director

The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”

By Helena Kudiabor
15 April 2026 | 4 min read